Advertisement
  • February 11: The Week in Cancer News

    Millions miss cancer screenings, and commercial tobacco ban goes into effect for Navajo Nation after years of failed attempts.

    by Marci A. Landsmann

  • February 4: The Week in Cancer News

    CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.

    by Eric Fitzsimmons

  • January 28: The Week in Cancer News

    Pharmacies asked to stop turning immune-compromised people away for fourth shot, and fiber intake is associated with stronger immune response in people with melanoma.

    by Marci A. Landsmann

  • January 21: The Week in Cancer News

    Metastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.

    by Kevin McLaughlin

  • January 14: The Week in Cancer News

    Cancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients are lost to follow-up.

    by Eric Fitzsimmons

  • Cancer, On and Off Stage

    Erin Cronican, who has stage IV breast cancer, plays the lead role of a professor diagnosed with metastatic ovarian cancer in the New York City production of Wit.

    by Pamela Rafalow Grossman

  • January 7: The Week in Cancer News

    Three out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit smoking experience increased survival.

    by Marci A. Landsmann

  • Acknowledging the Stress of Cancer

    A patient advocate session at the San Antonio Breast Cancer Symposium offered practical tips for dealing with cancer.

    by Marci A. Landsmann

  • Survivor Profile

    Strength in the Pack

    While undergoing treatment for colon cancer, Trevor Maxwell started Man Up to Cancer, a support community for men.

    by Jon Kelvey

  • Forward Look

    CAR T Cells for Blood Cancer Patients

    Researchers aim to minimize disease relapses by targeting multiple proteins.

    by Erin O'Donnell